Updates

Become a member

Become an ASPIC member and be part of the largest organization for cancer researchers in Europe - EACR

Sign in
Make a donation

Cancer research is the better answer for better patient's care. Your donation is important

How to donate
For Patients
See More

News

Wednesday, 01.07.2026
Functional assays for the classification of genetic variants in Lynch syndrome
Friday, 26.06.2026
Dual immune evasion mechanism shapes MMR-deficient colorectal tumors
Monday, 06.04.2026
Natural-inspired flavonoid derivatives show promising activity against leukemia cells
Monday, 23.03.2026
One-second 3D scanning: Innovation in breast cancer surgery
View All

Meetings

Tuesday, 06.10.2026
The EACR Conference on Cancer Metabolism
Wednesday, 07.10.2026
4th International Conference Therapeutic Applications of Nitric Oxide in Cancer and Related-Inflammatory Disorders
Wednesday, 14.10.2026
CRSy26 - Champalimaud Research Symposium 2026: «Neural and Immune Codes in Cancer»
Friday, 23.10.2026
Triple-Negative Breast Cancer (TNBC) Workshop - What is New | What Comes Next
View All
Become a member

Become an ASPIC member and be part of the largest organization for cancer researchers in Europe - EACR

Sign in
Make a donation

Cancer research is the better answer for better patient's care. Your donation is important

How to donate
For Patients
See More
EACR

A EACR é a associação profissional europeia para aqueles que trabalham e estudam na investigação do cancro.

Link

Jobs

Study Coordinator for Cancer Clinical Trials
Wednesday, 07.10.2026

IDIBELL, Barcelona, Spain

 

Deadline for Applications: 07 October, 2026

 

Postdoctoral Researcher
Thursday, 15.10.2026

The Nencki Institute of Experimental Biology, Warsaw, Poland

 

Postdoctoral Researcher Positions (Researcher/Senior Researcher)
Monday, 19.10.2026

University of Turku, Turku, Finland

 

Deadline for Applications: 19 October, 2026

Assistant Professor of Cancer Research Institute
Thursday, 22.10.2026

Kanazawa University, Ishikawa, Japan

 

View All

Partners

View All
IPO Porto
AstraZeneca